Pádraig O'Sullivan (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

132. To ask the Minister for Health further to Parliamentary Question No. 158 of 22 May 2024, when the HSE executive management team will be in a position to approve or make a decision on the reimbursement application for dostarlimab (jemperli) indicated as monotherapy for the treatment of adult patients with recurrent or advance endometrial cancer; and if he will make a statement on the matter. [25807/24]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.